Who Exports Gabapentin from India — 369 Suppliers Behind a $858.7M Market
India's gabapentin export market is supplied by 369 active exporters who collectively shipped $858.7M across 12,464 shipments. ALKEM LABORATORIES LIMITED leads with a 33.7% market share, followed by SANDOZ PRIVATE LIMITED and STRIDES PHARMA SCIENCE LIMITED. The top 5 suppliers together control 68.5% of total export value, reflecting a concentrated market structure.
Top Gabapentin Exporters from India — Ranked by Export Value
ALKEM LABORATORIES LIMITED is the leading gabapentin exporter from India, holding a 33.7% share of the $858.7M market across 12,464 shipments from 369 exporters. The top 5 suppliers — ALKEM LABORATORIES LIMITED, SANDOZ PRIVATE LIMITED, STRIDES PHARMA SCIENCE LIMITED, GLENMARK PHARMACEUTICALS LIMITED, WATSON PHARMA PRIVATE LIMITED — collectively control 68.5% of total export value, indicating a moderately concentrated market. Individual shares are: ALKEM LABORATORIES LIMITED (33.7%), SANDOZ PRIVATE LIMITED (16.4%), STRIDES PHARMA SCIENCE LIMITED (8.8%), GLENMARK PHARMACEUTICALS LIMITED (4.9%), WATSON PHARMA PRIVATE LIMITED (4.6%).
Top Gabapentin Exporters from India
Ranked by export value · 369 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ALKEM LABORATORIES LIMITED GABAPENTIN 300MG HARD CAPSULES (GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492 | $289.6M | 5 | 33.7% |
| 2 | SANDOZ PRIVATE LIMITED GABAPENTIN HGC 300MG IN91 SH EU 03 MATERIAL NO. - 42028364MATERIAL NO. - 42028358, GABAPENTIN HGC100MG IN91 SH EU 03,GABAPENTIN HGC 300MG IN91 SH EU 03 MATER | $141.0M | 6 | 16.4% |
| 3 | STRIDES PHARMA SCIENCE LIMITED GABAPENTIN 300MG HARD CAPSULES (GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492 | $75.7M | 4 | 8.8% |
| 4 | GLENMARK PHARMACEUTICALS LIMITED GABAPENTIN HGC 300MG IN91 SH EU 03 MATERIAL NO. - 42028364GABAPENTIN 300MG HARD CAPSULES (GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABS | $42.3M | 8 | 4.9% |
| 5 | WATSON PHARMA PRIVATE LIMITED GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492 | $39.1M | 2 | 4.6% |
| 6 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492 | $34.0M | 1 | 4.0% |
| 7 | ZYDUS LIFESCIENCES LIMITED GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492GABAPENTIN CAPSULES 300MG(GABAPENTINE AR | $32.9M | 3 | 3.8% |
| 8 | APEX LABORATORIES PRIVATE LIMITED GABAPENTIN 300MG HARD CAPSULES (GABAPENTIN CAPSULES 100MG(GABAPENTIN MILGABAPENTIN 300MG CAPSULES | $30.5M | 2 | 3.5% |
| 9 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492 | $27.0M | 2 | 3.1% |
| 10 | AUROBINDO PHARMA LTD GABAPENTIN 300MG HARD CAPSULES (GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492 | $26.9M | 19 | 3.1% |
| 11 | MICRO LABS LIMITED GABAPENTIN 300MG HARD CAPSULES (GABAPENTIN CAPSULES 100MG(GABAPENTIN MILCAP.GABANIN 100 (GABAPENTIN CAPSULES USP | $22.7M | 21 | 2.6% |
| 12 | GRANULES INDIA LIMITED GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492GABAPENTIN CAPSULES 300MG(AURO-GABAPENTI | $14.5M | 2 | 1.7% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LIMITED GABAPENTIN CAPSULES 300MG ( GABARAN CAPSGABAPENTIN CAPSULES 400MG ( GABARAN CAPSGABAPENTIN-MICRO LABS 300 MG HARTKAPSELN | $13.0M | 11 | 1.5% |
| 14 | HETERO LABS LIMITED GABAPENTIN 300MG HARD CAPSULES (GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492 | $11.6M | 3 | 1.3% |
| 15 | MARKSANS PHARMA LIMITED GABAPENTIN 300MG HARD CAPSULES (GABAPENTIN TABLETS 600MG - 5184 PAC X 1X90 TABSGABAPENTIN CAPSULES USP 100MG 500S (9492 | $9.1M | 4 | 1.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Gabapentin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Warning Letter issued in | Unknown | Unknown | Unknown | FDA issued a warning letter citing CGMP violations at the Pithampur facility. |
| Aurobindo Pharma Ltd | Approved | Yes, as of 2024 | Yes | Over 200 | Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications. |
| Sun Pharmaceutical Industries Limited | Approved | Yes, as of 2023 | Yes | Over 400 | Extensive portfolio of FDA-approved products with WHO-GMP and EU GMP certificati |
| Hetero Labs Limited | Approved | Yes, as of 2024 | Yes | Over 100 | Maintains FDA approvals along with WHO-GMP and EU GMP certifications. |
| Zydus Lifesciences Limited | Approved | Yes, as of 2023 | Yes | Over 150 | Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications. |
| Strides Pharma Science Limited | Approved | Yes, as of 2024 | Yes | Over 80 | Maintains FDA approvals along with WHO-GMP and EU GMP certifications. |
| Glenmark Pharmaceuticals Limited | Warning Letter issued in | Unknown | Unknown | Unknown | FDA issued a warning letter citing CGMP violations at the Pithampur facility. |
| Aurobindo Pharma Ltd | Approved | Yes, as of 2024 | Yes | Over 200 | Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications. |
| Sun Pharmaceutical Industries Limited | Approved | Yes, as of 2023 | Yes | Over 400 | Extensive portfolio of FDA-approved products with WHO-GMP and EU GMP certificati |
| Hetero Labs Limited | Approved | Yes, as of 2024 | Yes | Over 100 | Maintains FDA approvals along with WHO-GMP and EU GMP certifications. |
| Zydus Lifesciences Limited | Approved | Yes, as of 2023 | Yes | Over 150 | Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications. |
| Strides Pharma Science Limited | Approved | Yes, as of 2024 | Yes | Over 80 | Maintains FDA approvals along with WHO-GMP and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 12 leading Gabapentin exporters from India. 10 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Gabapentin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredient (API) manufacturing, including gabapentin. The city hosts numerous pharmaceutical companies specializing in API production. For instance, Granules India Limited, based in Hyderabad, is a vertically integrated pharmaceutical company that manufactures APIs, including gabapentin, serving customers in over 80 countries. Additionally, Smilax Laboratories Limited, located in Hyderabad, offers gabapentin as part of its anticonvulsant API range. The presence of such companies underscores Hyderabad's significant role in the gabapentin supply chain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. Alembic Pharmaceuticals manufactures and markets pharmaceutical products, including APIs and formulations, and has a presence in the macrolide anti-infective drug segment. The region's robust infrastructure and skilled workforce make it a key player in the production and export of gabapentin formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products, including gabapentin. This region's strategic location and well-developed port facilities facilitate efficient international distribution. Pharmaceutical companies in this area benefit from proximity to major shipping routes, enhancing their export capabilities. The region's infrastructure supports the storage and transportation needs essential for maintaining the quality and compliance of pharmaceutical exports.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the area. The region's growth has contributed to the diversification and expansion of India's pharmaceutical manufacturing capabilities, including the production of gabapentin.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different regions, such as Hyderabad for APIs and Ahmedabad-Vadodara for formulations, to mitigate risks associated with regional disruptions.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to ensure efficient and compliant international distribution of gabapentin products.
- Monitor Regulatory Compliance: Regularly review and ensure that suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and market access.
- Assess Cost Benefits: Evaluate the financial advantages of sourcing from tax incentive zones like Baddi-Nalagarh, balancing cost savings with logistical considerations.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Gabapentin exporters from India
Glenmark Pharmaceuticals Limited — Glenmark divests 75% stake in Glenmark Life Sciences to Nirma Limited
In July 2025, Glenmark Pharmaceuticals completed the sale of a 75% stake in its subsidiary, Glenmark Life Sciences, to Nirma Limited for approximately ₹5,651 crore. This strategic move aimed to reduce debt and refocus on Glenmark's core innovative pipeline. - IMPACT: The divestment may lead to a reallocation of resources, potentially affecting Glenmark's Gabapentin production and export strategies.
Impact: The divestment may lead to a reallocation of resources, potentially affecting Glenmark's Gabapentin production and export strategies.
Common Questions — Gabapentin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which gabapentin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ALKEM LABORATORIES LIMITED leads with 546 recorded shipments worth $289.6M. SANDOZ PRIVATE LIMITED (224 shipments) and STRIDES PHARMA SCIENCE LIMITED (299 shipments) are also established high-volume exporters.
Q How many gabapentin manufacturers are there in India?
India has 369 active gabapentin exporters with a combined export market of $858.7M across 12,464 shipments to 123 countries. The top 5 suppliers hold 68.5% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for gabapentin from India?
Average FOB unit price: $13.33 per unit, ranging from $0.00 to $2262.90. Average shipment value: $68.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 369 verified Indian exporters of Gabapentin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 12,464 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 123 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12,464 Verified Shipments
369 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists